Fig. 5

Frequencies of circulating HLA-DR+lowCD14+ MDSC at baseline and 3 months. a Levels of circulating monocytic HLA-DR+lowCD14+ MDSC were lower at baseline in the relapse-free group. b Median levels increased in the non-relapsed groups at 3 months while staying the same in the relapsed group, but there were no significant differences in levels of MDSC at 3, 6, or 9 months between the 2 groups